PRODUCT DETAILS

Product Image

KERENDIA-20MG-14 TABLETS (Finerenone 20mg) CKD Treatment

$

KERENDIA-20MG-14 TABLETS contain Finerenone 20mg, a prescription mineralocorticoid receptor antagonist used to slow chronic kidney disease progression and reduce cardiovascular risk in adults with CKD associated with type 2 diabetes.

Unit:
  • N/A
Total: $

 KERENDIA-20MG-14 TABLETS (Finerenone 20mg) CKD Treatment

 KERENDIA-20MG-14 TABLETS contain Finerenone 20mg, a prescription mineralocorticoid receptor antagonist used to slow chronic kidney disease progression and reduce cardiovascular risk in adults with CKD associated with type 2 diabetes.

        KERENDIA-20MG-14 TABLETS

KERENDIA-20MG-14 TABLETS (FINERENONE 20MG): Comprehensive Guide and Benefits

Introduction to KERENDIA-20MG-14 TABLETS (FINERENONE 20MG)

KERENDIA-20MG-14 TABLETS (FINERENONE 20MG): A Non-Steroidal Mineralocorticoid Receptor Antagonist

KERENDIA-20MG-14 TABLETS contain Finerenone 20mg, a non-steroidal mineralocorticoid receptor antagonist (MRA) indicated for adults with chronic kidney disease (CKD) associated with type 2 diabetes. It helps reduce the risk of kidney function decline, end-stage kidney disease, cardiovascular death, heart attack, and hospitalization for heart failure when used alongside standard medical care.

Finerenone works by blocking overactivation of mineralocorticoid receptors, reducing inflammation and fibrosis in the kidneys and cardiovascular system. This medicine is prescription-only and requires regular monitoring of kidney function and serum potassium because treatment may increase potassium levels (hyperkalemia).

Key Benefits of KERENDIA-20MG-14 TABLETS (FINERENONE 20MG)

Helps slow the progression of chronic kidney disease associated with type 2 diabetes.

Reduces the risk of cardiovascular death and heart failure hospitalization.

Helps preserve kidney function over time.

Reduces the likelihood of end-stage kidney disease.

Provides targeted non-steroidal mineralocorticoid receptor blockade.

How KERENDIA-20MG-14 TABLETS (FINERENONE 20MG) Works

Finerenone selectively blocks the mineralocorticoid receptor, preventing excessive receptor activation that promotes inflammation and fibrosis within the kidneys, heart, and blood vessels. By reducing these harmful processes, it slows kidney damage progression and lowers the risk of cardiovascular complications in eligible patients with chronic kidney disease associated with type 2 diabetes.

Usage Instructions for KERENDIA-20MG-14 TABLETS (FINERENONE 20MG)

Take exactly as prescribed by your healthcare provider.

Swallow the tablet whole with water; it may be taken with or without food.

Take it at the same time every day.

Attend regular blood tests to monitor kidney function and serum potassium.

Do not stop treatment without consulting your physician.

Medicinal Advantages of KERENDIA-20MG-14 TABLETS (FINERENONE 20MG)

Clinically proven to slow CKD progression in adults with type 2 diabetes.

Lowers the risk of major cardiovascular complications.

Helps reduce hospitalization due to heart failure.

Offers selective, non-steroidal mineralocorticoid receptor inhibition.

Supported by evidence-based clinical trials and treatment guidelines. 

NOTE: KERENDIA-20MG-14 TABLETS are prescription-only medicines. Serum potassium and kidney function should be assessed before starting treatment and monitored regularly. Avoid use with strong CYP3A4 inhibitors unless specifically directed by your physician.

Off-Label Uses of KERENDIA-20MG-14 TABLETS (FINERENONE 20MG)

Healthcare professionals may occasionally consider finerenone for selected patients based on emerging clinical evidence and specialist judgment.

Selected cases of non-diabetic chronic kidney disease.

Certain cardiovascular conditions under specialist supervision.

Individualized nephrology treatment strategies.

Disclaimer: Off-label uses should only occur under physician supervision and may not be approved in all countries.

Expert Advice for Optimal Use

Take the medicine consistently every day.

Attend all scheduled potassium and kidney function tests.

Avoid potassium supplements unless prescribed.

Inform your healthcare provider about all medicines you take.

Avoid grapefruit and grapefruit juice during treatment.

Follow your recommended diabetes and kidney care plan.

Precautions

Cardiovascular Health

KERENDIA helps reduce cardiovascular complications but should be used carefully in patients with severe heart disease. Regular clinical monitoring is recommended.

Liver & Kidney Function

Assess kidney function before initiating therapy and monitor throughout treatment. Patients with significant liver impairment require careful evaluation before use.

Pregnancy & Breastfeeding

Use during pregnancy only if clearly needed and prescribed. Discuss breastfeeding with your healthcare provider before using finerenone.

Drug Interactions

Finerenone may interact with strong CYP3A4 inhibitors, CYP3A4 inducers, potassium supplements, potassium-sparing diuretics, ACE inhibitors, ARBs, and other medicines that increase potassium levels. Always inform your healthcare provider about all medicines you use.

Existing Medical Conditions

Use cautiously in patients with hyperkalemia, severe kidney impairment, adrenal disorders, significant liver disease, or electrolyte abnormalities.

Storage Instructions

Store below 30°C.

Keep the tablets in their original packaging.

Protect from moisture and direct sunlight.

Keep out of reach of children.

Do not use after the expiry date.

Frequently Asked Questions (FAQs)

Q: What is KERENDIA-20MG-14 TABLETS used for?

A: It is used to reduce the progression of chronic kidney disease associated with type 2 diabetes and lower the risk of cardiovascular complications.

Q: How does KERENDIA work?

A: It blocks mineralocorticoid receptors, helping reduce inflammation and fibrosis that contribute to kidney and heart damage.

Q: Can I take KERENDIA with food?

A: Yes. It may be taken with or without food unless your healthcare provider advises otherwise.

Q: Why are regular blood tests necessary?

A: Blood tests monitor kidney function and potassium levels, helping detect hyperkalemia or changes in renal function early.

Q: What are the common side effects?

A: Common side effects include hyperkalemia (high potassium), low blood pressure, and decreased sodium levels.

Q: Should grapefruit be avoided during treatment?

A: Yes. Grapefruit and grapefruit juice may increase finerenone levels, raising the risk of side effects.

Q: Is KERENDIA-20MG-14 TABLETS available without a prescription?

A: No. It is a prescription-only medicine and should only be used under the supervision of a qualified healthcare professional.

Product Tags

KERENDIA-20MG-14 TABLETS, Finerenone 20mg, Finerenone Tablet, Mineralocorticoid Receptor Antagonist, Non-Steroidal MRA, Chronic Kidney Disease Medicine, CKD Treatment, Type 2 Diabetes Kidney Disease, Diabetic Kidney Disease, Kidney Protection Medicine, Cardiovascular Risk Reduction, Prescription Kidney Medicine, Hyperkalemia Monitoring, Finerenone 20mg Tablet, Renal Protection Therapy, Heart Failure Risk Reduction, KERENDIA Tablet, Prescription Finerenone, CKD Associated with Type 2 Diabetes, Kidney Health Medicine.

Jonathan Andrew

Happy Customer

Review

Post Your Review